Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Derma Sciences, a provider of advanced wound care products, has signed an agreement with MedEfficiency for the exclusive distribution of the company's novel total contact casts.
Subscribe to our email newsletter
According to MedEfficiency, the TCC-EZ cast will act as a protective barrier for the open wounds that often develop on the undersides of diabetic patients’ feet, and help to greatly reduce the over 80,000 diabetes-related lower extremity amputations that are performed annually in the US, at a cost of over $2.5 billion for the hospital system.
The TCC-EZ also provides additional support and stability for the patient, thus reducing the likelihood of post-treatment injuries as well.
Ed Quilty, CEO of Derma Sciences, said: “Our goal is advancing wound care by uncovering novel technologies, empowering caregivers, and focusing on patients’ unmet needs.
“Helping to bring the TCC-EZ cast to market achieves all three. If we are able to increase adoption of a technology that is considered the gold standard for treatment of diabetic foot ulcers, we feel confident this will lead to fewer amputations.”